irisin glp-1 Frontiers Frontiers | Beyond GLP-1: underexplored

It has a natural yellow pigment (dye) which also shows as bright yellow fluorescence under UV light.

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication

The role of GLP-1 RAs was also investigated using the Inverse Probability Treatment Weighting (IPTW) and in the subgroup analyses

has details on the plan to remove auto-injectors in order to allow greater access to patients at lower prices.

Struggling with GLP-1 therapy side effects